Chronic obstructive pulmonary disease (COPD) affects 25 million people in the U.S. and is the fifth leading cause of death ...

Researchers looked at lung tissue from 28 COPD patients and 15 smokers who underwent surgery for suspected or confirmed lung ...

Among patients with COPD and type 2 inflammation, investigator-reported emphysema did not change benefits seen with dupilumab ...

COPD patients who receive intensive guidance from a hospital pharmacist during their stay use their inhalation medication ...

In those cases, each standard deviation increase in VMR was tied to a 50% higher likelihood of experiencing a major adverse ...

Regardless of chronic obstructive pulmonary disease status, finerenone mitigates clinical events and symptoms in patients with HFmrEF or HFpEF.

Researchers discover an unusual accumulation of particles in people with the disease; the causes are still unclear.

Long-term health care utilization is greater among patients with COPD who have tested positive for COVID-19 and are unvaccinated.

Quantitative CT textures may provide imaging evidence of the spatial heterogeneity of lung inflammation and disease burden in COPD.

Long-term oxygen therapy (LTOT) is linked to reduced exacerbations and hospitalizations in COPD, ILD, and pulmonary hypertension.